High-dose selection with mafosfamide results in sensitivity to DNA cross-linking agents: Characterization of hypersensitive cell lines

Cancer Research

Volumn 57, Issue 3, 1997, Pages 454-460

  Fritz, Gerhard ^a   Hengstier, Jan Georg ^a   Kaina, Bernd ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ELMUSTINE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; MAFOSFAMIDE; MELPHALAN; MESSENGER RNA; MITOMYCIN C; PROTEIN P53; TREOSULFAN;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL KILLING; CELL SELECTION; CHO CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA CROSS LINKING; DNA REPAIR; DRUG MEGADOSE; DRUG RESISTANCE; DRUG SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; UNSCHEDULED DNA SYNTHESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CHO CELLS; CHROMOSOME ABERRATIONS; CRICETINAE; CYCLOPHOSPHAMIDE; DNA; DNA DAMAGE; DNA REPAIR; DNA REPLICATION;

EID: 0031057098     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Jones, N. J., Stewart, S. A., and Thompson, L. H. Biochemical and genetic analysis of the Chinese hamster mutants irs1 and irs2 and their comparison to cultured ataxia telangiectasia cells. Mutagenesis, 5:15-23, 1990.
2. Thompson, L. H., Brookman, K. W., Dillehay, L. E., Carran, A. V., Carrano, A. V., Mazrimas, J. A., Mooney, C. L., and Minkler, J. L. A CHO strain having hypersen sitivity to mutagens' defect in DNA strand break repair and an extraordinary baseline frequency of sister-chromatid exchange. Mut. Res., 95:427-440, 1982.
3. Thompson, L. H., and Jeggo, P. A. Nomenclature of human genes involved in ionizing radiation sensitivity. Mut. Res., 337:131-134, 1995.
4. Zdzienicka, M. Z., Simons, J. W. I. M., and Lohman, P. H. M. Chinese hamster cell lines defective in DNA repair. In:M. W. Lambert and J. Laval (eds.), DNA Repair Mechanisms and their Biological Implications in Mammalian Cells, pp. 535-545. New York: Plenum Publishing Corp., 1989.
5. Weber, C. A., Salazar, E. P., Stewart, S. A., and Thompson, L. H. ERCC2:cDNA cloning and molecular characterization of a human nucleotide excision repair gene with high homology to yeast RAD3. EMBO J., 9; 1437-1447, 1990.
6. Weeda, G., Van Ham, R. C. A., Masurel, R., Westerveld, A., Odijk, H., De Wit, J., Bootsma, D., Van Der Eb, A. J., and Hoeijmakers, J. H. J. Molecular cloning and biological characterization of the human excision repair gene ERCC-3. Mol. Cell. Biol., 10:2570-2581, 1990.
7. Weeda, G., Van Ham, R. C. A., Vermeulen, W., Bootsma, D., Van Der Eb, A. J., and Hoeijmakers, J. H. J. A presumed DNA helieuse encoded by ERCC-3 is involved in the human repair disorders xeroderma pigmentosum and Cockayne's syndrome. Cell, 62:777-791, 1990.
8. Thompson, L. H., Brookman, K. W., Jones, N. J., Alien, S. A., and Carrano, A. V. Molecular cloning of the human XRCCI gene which corrects defective DNA strand break repair and sister chromatid exchange. Mol. Cell. Bid., 10:6160-6171, 1990.
9. Jones, N. J., Ellard, S., Waters, R., and Parry, E. M. Cellular and chromosomal hypersensitivity to DNA crosslinking agents and topoisomerasc inhibitors in the radiosensitive Chinese hamster irs mutants:phenotypic similarities to ataxia telangiectasia and Fanconi's anemia cells. Carcinogenesis (Lond.), 14: 2487-2494, 1993.
10. Savitsky, K., Bar-Shia, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Patanjali, S. R., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., Sanal, O., Lavin, M. F., Jaspers, N. G. J., Taylor, A. M. R., Arlett, C. F., Miki, T., Weissman, S. M., Lovett, M., Collins, F. S., and Shiloh, Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (Washington DC). 268:1749-1753, 1995.
11. Fujiwara, Y., Tatsumi, M., and Sasaki, M. S. Cross-link repair in human cells and its possible defect in Fanconi's anemia cells. Mol. Cell. Biol., 113:635-649, 1977.
12. Strathdee, C. A., Gavish, H., Shannon, W. R., and Buchwald, M. Cloning of cDNAs for Fanconi's anemia by functional complementation. Nature (Lond.), 356:763-767, 1992.
13. Tanaka, K., Satokata, I., Ogita, Z., Uchida. T., and Okada, Y. Molecular cloning of a mouse DNA repair gene that complements the defect of group-A xeroderma pigmentosum, Proc. Natl. Acad. Sci. USA, 87:5512-5516, 1989.
14. Legerski, R., and Peterson, C. Expression cloning of a human DNA repair gene involved in xeroderma pigmentosum group C. Nature (Lond.), 359:70-73, 1992.
15. Meyn, R. E., Jenkins, S. F., and Thompson, L. H. Defective removal of DNA cross-links in a repair-deficient mutant of Chinese hamster cells. Cancer Res., 42:3106-3110, 1982.
16. Caldecott, K., and Jeggo, P. Cross-sensitivity of X-ray-sensitive hamster mutants to cross-linking agents. Mut. Res., 255:111-121, 1991.
17. Overkamp, W. J., Rooimans, M. A., Neuteboom, I., Telleman, P., Arwert, F., and Zdzienicka, M. Z. Genetic diversity of mitomycin C-hypersensitive Chinese hamster cell mutants:a new complementation group with chromosomal instability. Somat. Cell Mol. Genet., 19: 431-437, 1994.
18. Hoy, C. A., Thompson, L. H., and Mooney, S. L. Defective DNA cross-link removal in Chinese hamster cell mutants hypersensitive to bifunctional alkylating agents. Cancer Res., 45:1737-1745, 1985.
19. Bramson, J., and Panasci, L. C. Effect of ERCC-1 overexpression on sensitivity of Chinese hamster ovary cells to DNA damaging agents. Cancer Res., 53:3237-3240, 1993.
20. Batist, G., Torres-Garcia, S., Demuys, J. M., Greene, D., Lehnert, S., Rochon, M., and Panasci, L. Enhanced DNA cross-link removal:the apparent mechanism of resistance in a clinically relevant melphalan-resislant human brest cancer cell line. Mol. Pharmacol., 36: 224-230, 1989.
21. Park, C. H., and Sancar, A. Formation of a ternary complex by human XPA, ERCC1 and ERCC4 (XPF) excision repair proteins. Proc. Natl. Acad. Sci. USA, 91:5017-5021, 1994.
22. Torres, S. J., Cousineau, L., Caplan, S., and Panasci, L. Correlation of resistance to nitrogen mustards in chronic lymphocytic leukemia with enhanced removal of melphalan-induced DNA crosslinks. Biochem. Pharmacol., 38:3122-3123, 1989.
23. Geleziunas, R., McQuillan, A., Malapetsa, A., Hutchinson, M., Kopriva, D., Wainberg, M. A., Hiscott, J., Bramson, J., and Panasci, L. Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards. J. Natl. Cancer Inst., 83:557-564, 1991.
24. Dabholkar, M., Bostick-Bruton, F., Weber, C., Bohr, V. A., Egwuagu, C., and Reed, E. ERCC-1 and ERCC-2 expression in malignant tissues from ovarian cancer patients. J. Natl. Cancer Inst., 84:1512-1517, 1992.
25. 6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents. Carcinogenesis (Lond.), 12:1857-1867, 1991.
26. 6-benzylguanine provides a mean to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc. Natl. Acad. Sci. USA, 87:5368-5372, 1990.
27. 6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res., 57:3367-3372, 1991.
28. 6-methylguaninc-DNAmetnyltmnsferase (MGMT) on the cytotoxic and recombinogenic activity of different antineoplastic drugs. Int. J. Cancer. 65:1-7, 1995.
29. Lückc-Huhle, C. H., Hinrichs, S., and Speit, G. DHFR gene amplification in cultured skin fibrohlasts of ataxia telangiectasia patients after methotrexate selection. Carcinogenesis (Lond.), 8:1801-1806, 1987.
30. Trent, J. M., Buick, R. N., Olson, S., Horns, R. C., and Schimke, R. T. Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma. J. Clin. Oncol., 2:8-15, 1984.
31. Kohno, K., Tanimura, H., Nakuyama, Y., Makino, Y., Wada, M., Fojo, A. T., and Kuwano, M. Cellular control of human multidrug resistance 1 (mdr-1) gene expression in absence and presence of gene amplification in human cancer cells. J. Biol. Chem.. 269:20503-20508, 1994.
32. Wani, M. A., Xu. X., and Stambrook, P. J. Increased methotrexate resistance and dhfr gene amplification as a consequence of induced Ha-ras expression in NIH3T3 cells. Cancer Res., 54:2504-2508, 1994.
33. Dong, Z., Radinsky, R., Fan, D., Tsan, R., Bucana, C. D., Wilmanns, C., and Fidler, I. J. Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells. J. Natl. Cancer Inst., 86:913-920, 1994.
34. Goth-Goldstein, R. MNNG-induced partial phcnoiypic reversion of Mer- cells. Carcinogenesis (Lond.), 5: 1449-1453, 1987,
35. Goldmacher, V. S., Cuzick, R. A., and Thilly, W. G. Isolation and partial characterization of human cell mutants differing in sensitivity to killing and mutation by methylnitrosourea and N-methyl-N'-nitro-N-nitrosoguanidine. J. Biol. Chem., 261:12462-12471, 1986.
36. Durrant, L. G., Margison, G. P., and Boyle, J. M. Pretreatment of Chinese Hamster V79 cells with MNU increases survival without affecting DNA repair or mutagenicity. Carcinogenesis (Lond.), 2:55-60, 1981.
37. Griffin, S., Branch, P., Xu, Y., and Karran, P. DNA mismatch binding and incision at modified guanine bases by extracts of mammalian cells: implications for tolerance to DNA methylation damage. Biochemistry, 33:4787-4793, 1994.
38. De Wind, N., Dekker, M., Berns, A., Radman, M., and De Riele, H. Inactivation of the Mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination and predisposition to cancer. Cell, 82:321-330, 1995.
39. Modrich, P. Mismatch repair, genetic stability and cancer. Science (Washington DC), 266: 1959-1960, 1994.
40. Crook, T, R., Souhami, R. L., and McLean, A. E. M. Cytotoxicity, DNA cross-linking and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells. Cancer Res., 46:5029-5034, 1986.
41. Parsons, P. G., Lean, J., Kuble, E. P., Favier, D., Khoo, S. K., Hurst, T., Holmes, R. S., and Bellet, A. J. Relationships between resistance to cross-linking agents and glutathione metabolism, aldehyde dehydrogenase isoenzymes and adenovirus replication in human tumour cell lines. Biochem. Pharmacol., 40:2641-2649, 1990.
42. 6-benzylguanine and ethacrynic acid in haemalological malignancies. Anticancer Res., 13:2155-2159, 1993.
43. Schuler, U., Ehninger, G., and Wagner, T. Repeated high-dose cyclophosphamide administration in bone marrow transplantation:exposure to activated metabolites. Cancer Chemother. Pharmacol., 20: 248-252, 1987.
44. Goldenberg, G. J. The role of drug transport in resistance to nitrogen mustard and other alkylating agents in L5178Y lymphoblasts. Cancer Res., 35: 1687-1692, 1975.
45. Hengstler, J. G., Fuchs, J., and Oesch, F. DNA strand break and DNA cross-links in peripheral mononuclear blood cells of ovarian cancer patients during chemotherapy with cyclophosphamide/Carboplaiin. Cancer Res., 52:5622-5626, 1992.
46. Hengstler, J. G., Fuchs, J., Gebhard, S., and Oesch, F. Glycol aldehyde causes DNA-protein crosslinks: a new aspect of ethylene oxide genotoxicity. Mut. Res., 304:229-234, 1994.
47. Oesch, F., Hengstler, J. G., and Fuchs, J. Cigarette smoking protects mononuclear blood cells of carcinogen exposed workers from additional work exposure-induced DNA single strand breaks. Mut. Res., 327:175-185, 1994.
48. Griffith, O. W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem., 706: 207-212, 1980.
49. Glatt, H., Gemperlein, I., Setiabudi, F., Platt, K. L., and Oesch, F. Expression of xenobiotic-metabolizing enzymes in propagatable cell cultures and induction of micronuclei by 13 compounds. Mutagenesis, 5:241-249, 1990.
50. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantity of proteins utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
51. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 762:156-159, 1987.
52. Schreiber, M., Baumann, B., Cotton, M., Angel, P., and Wagner, E. F. Fos is an essential component of the mammalian UV response. EMBO J., 14:5338-5349, 1995.
53. Haas, S., and Kaina, B. c-Fos is involved in the cellular defence against the genotoxic effect of UV radiation. Carcinogenesis (Lond.), 16:985-991, 1995.
54. Moustacchi, E., and Diatloff-Zito, C. DNA semi-conservative synthesis in normal and Fanconi anemia fibroblasts following treatment with 8-methoxypsoralen and near ultraviolet light or with X-rays. Hum. Genet., 75:45-47, 1987.
55. Robson, C. N., and Hickson, I. D. Isolation of alkylating agent-sensitive Chinese hamster ovary cell. Carcinogenesis (Lond.), 8:601-605, 1987.
56. Digweed, M., Günthert, U., Schneider, R., Seyschab, H., Friedl, R., and Sperling, K. Irreversible repression of DNA synthesis in Fanconi anemia cells is alleviated by the product of a novel cyclin-related gene. Mol. Cell. Biol., 75:305-314, 1995.